Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes

Shyny Koshy, Danli Wu, Xueyou Hu, Rajeev B. Tajhya, Redwan Huq, Fatima S. Khan, Michael W. Pennington, Heike Wulff, Patricia Yotnda, Christine Beeton

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.

Original languageEnglish (US)
Article numbere76740
JournalPLoS One
Volume8
Issue number10
DOIs
StatePublished - Oct 11 2013

Fingerprint

Lymphocytes
natural killer cells
Natural Killer Cells
Tumors
lymphocytes
Cells
Kv1.3 Potassium Channel
Neoplasms
Chemokine Receptors
Pathogens
Cytotoxicity
Mitogens
Grafts
Assays
Chemical activation
neoplasms
TRAM 34
neoplasm cells
Up-Regulation
graft rejection

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Koshy, S., Wu, D., Hu, X., Tajhya, R. B., Huq, R., Khan, F. S., ... Beeton, C. (2013). Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes. PLoS One, 8(10), [e76740]. https://doi.org/10.1371/journal.pone.0076740

Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes. / Koshy, Shyny; Wu, Danli; Hu, Xueyou; Tajhya, Rajeev B.; Huq, Redwan; Khan, Fatima S.; Pennington, Michael W.; Wulff, Heike; Yotnda, Patricia; Beeton, Christine.

In: PLoS One, Vol. 8, No. 10, e76740, 11.10.2013.

Research output: Contribution to journalArticle

Koshy, S, Wu, D, Hu, X, Tajhya, RB, Huq, R, Khan, FS, Pennington, MW, Wulff, H, Yotnda, P & Beeton, C 2013, 'Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes', PLoS One, vol. 8, no. 10, e76740. https://doi.org/10.1371/journal.pone.0076740
Koshy, Shyny ; Wu, Danli ; Hu, Xueyou ; Tajhya, Rajeev B. ; Huq, Redwan ; Khan, Fatima S. ; Pennington, Michael W. ; Wulff, Heike ; Yotnda, Patricia ; Beeton, Christine. / Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes. In: PLoS One. 2013 ; Vol. 8, No. 10.
@article{49f7e05eb45a400c8c2aba571c1f2131,
title = "Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes",
abstract = "Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.",
author = "Shyny Koshy and Danli Wu and Xueyou Hu and Tajhya, {Rajeev B.} and Redwan Huq and Khan, {Fatima S.} and Pennington, {Michael W.} and Heike Wulff and Patricia Yotnda and Christine Beeton",
year = "2013",
month = "10",
day = "11",
doi = "10.1371/journal.pone.0076740",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes

AU - Koshy, Shyny

AU - Wu, Danli

AU - Hu, Xueyou

AU - Tajhya, Rajeev B.

AU - Huq, Redwan

AU - Khan, Fatima S.

AU - Pennington, Michael W.

AU - Wulff, Heike

AU - Yotnda, Patricia

AU - Beeton, Christine

PY - 2013/10/11

Y1 - 2013/10/11

N2 - Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.

AB - Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84885396493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885396493&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0076740

DO - 10.1371/journal.pone.0076740

M3 - Article

C2 - 24146918

AN - SCOPUS:84885396493

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e76740

ER -